| Antigen | 17-aa peptide from human WNK-1 (1); Designation (WNK11-P, control or blocking peptide) conjugated to KLH; epitope location ~ N-terminus and prior to the tyrosine kinase catalytic domain |
| Form | Antiserum Unpurified |
| Product Type | Primary Antibodies |
| SpCrossreactivity | WNK11-P peptide is 100% conserved in rat and human WNK1. No significant sequence homology of WNK11-P is seen with other WNKs or other kinases. Antibody reactivity in various species is not known |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |